Schwarzes Brett

Adalimumab may be effective treatment for juvenile rheumatoid arthritis, report suggests

• Abstrakt

Bericht über klinische Studien

Zoledronic acid in the management of osteoporosis: the HORIZON trials

E Michael Lewiecki

• Abstrakt

Arzneimittelbewertung

Desloratadine: a review of pharmacology and clinical efficacy in allergic rhinitis and urticaria

Evrim Alyamac Dizdar, Bulent Enis Sekerel and Ayfer Tuncer

• Abstrakt

Arzneimittelbewertung

Ranolazine extended-release for chronic angina

Laura M Gruen and Carl J Pepine

• Abstrakt

Leitartikel

The search for new anticoagulants: dabigatran etexilate

Aurangzeb Siddique, Eduard Shantsila and Gregory YH Lip

• Abstrakt

Anhänge

Author guidelines: Volume 5 Issue 6

• Abstrakt

Anhänge

Acknowledgement: Volume 5 Issue 6

• Abstrakt

Anhänge

Compound Index: Volume 5 Issue 6

• Abstrakt

Anhänge

Author index: Volume 5 Issue 6

• Abstrakt

Anhänge

Glossary: Volume 5 Issue 6

• Abstrakt

Sonderbericht

Secondary hypertension: etiology and mechanism of disease

Jeffrey H Freihage, Aravinda Nanjundappa and Robert S Dieter

• Abstrakt

Rezensionsartikel

Weight-reducing drug therapy and hypertension

Julia Schimkus and Jurgen Scholze

• Abstrakt

Rezensionsartikel

Continuing evolution of the role of β-blockers in the treatment of hypertension

Thomas D Giles

• Abstrakt

Rezensionsartikel

Hypertension in practice: towards the year 2010

D Gareth Beevers

• Abstrakt

Arzneimittelbewertung

Clevidipine and the management of acute hypertension

Joseph Varon and Jorge E Angeles

• Abstrakt

Arzneimittelbewertung

Inhibition of endothelin-1 with darusentan: a novel antihypertensive approach for the treatment of resistant hypertension

Robert Weiss, Christopher A Graybill, Jennifer Linseman & Marshelle Warren

• Abstrakt

Interview

Web-based care: a new paradigm in hypertension management?

Beverly Green

• Abstrakt

Vorwort

Looking backwards and moving forwards in the therapy of hypertension

Robert J MacFadyen

• Abstrakt